News
MarketBeat on MSN4h
With Novo Nordisk's CEO Out, Wall Street Wants an American LeaderCompanyOverview|NYSE:NVO] Despite a massively successful run as Chief Executive Officer (CEO) of pharma giant Novo Nordisk ...
ORCL gains on strong cloud momentum, while NVO battles obesity headwinds and LIN leans on $10B backlog for growth.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback